Penn Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-276,378
| Closed | -$12M | – | 225 |
|
|
2019
Q2 | $12M | Sell |
276,378
-13,434
| -5% | -$584K | 1.19% | 15 |
|
|
2019
Q1 | $11M | Buy |
289,812
+65,073
| +29% | +$2.48M | 1.07% | 26 |
|
|
2018
Q4 | $12.3M | Sell |
224,739
-40,516
| -15% | -$2.22M | 1.22% | 17 |
|
|
2018
Q3 | $16.4M | Sell |
265,255
-76,325
| -22% | -$4.72M | 1.25% | 13 |
|
|
2018
Q2 | $11M | Sell |
341,580
-50,935
| -13% | -$1.65M | 0.82% | 51 |
|
|
2018
Q1 | $12.3M | Buy |
392,515
+58,218
| +17% | +$1.83M | 0.97% | 33 |
|
|
2017
Q4 | $15.4M | Buy |
334,297
+59,455
| +22% | +$2.74M | 1.07% | 18 |
|
|
2017
Q3 | $10.4M | Buy |
274,842
+32,549
| +13% | +$1.23M | 0.76% | 54 |
|
|
2017
Q2 | $11.6M | Buy |
242,293
+235,615
| +3,528% | +$11.3M | 0.86% | 47 |
|
|
2017
Q1 | $325K | Buy |
+6,678
| New | +$325K | 0.02% | 257 |
|